Subscribe free

Newsletter

Intestine and Lower Gastrointestinal Tract

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
J Surg Oncol9 Oct 2024

Neoadjuvant chemotherapy shows promise for survival in rectal cancer

A national database study of locally advanced rectal adenocarcinoma patients reveals that neoadjuvant chemotherapy (NAC) combined with chemoradiation (CRT) leads to better overall survival (OS) outcomes than CRT alone. Those receiving NAC alone exhibited poorer pathologic outcomes, specifically lower rates of R0 resection and pathologic…

Dig Surg9 Oct 2024

Intracorporeal anastomosis enhances recovery in laparoscopic surgeries

A systematic review of 720 patients revealed that while intracorporeal and extracorporeal anastomosis in laparoscopic right hemicolectomy presented no significant differences in anastomotic leakage (RR 0.93), the former showcased notable advantages. Intracorporeal anastomosis led to reduced postoperative ileus and surgical site infections, alongside quicker bowel…

Eur J Surg Oncol8 Oct 2024

MRI effectively assesses peritoneal cancer index in patients.

Results indicate that diffusion-weighted MRI (dw-MRI) demonstrates significant accuracy in evaluating the peritoneal cancer index (PCI) in colorectal cancer patients with peritoneal metastases. In a cohort of 87 patients, a strong correlation was found between MRI-derived PCI and histopathology (0.77), with surgical PCI showing excellent…

Asian J Surg8 Oct 2024

HALP score effectively predicts complicated acute diverticulitis

In a study involving 190 patients, the HALP score demonstrated significant potential in assessing the severity of acute diverticulitis. Key inflammatory markers and HALP scores were notably higher in complicated cases compared to uncomplicated ones, indicating robust prognostic value. ROC analysis revealed that the HALP…

Eur J Surg Oncol7 Oct 2024

Machine learning model predicts unplanned reoperation risk in rectal cancer

An optimized machine learning model was developed to predict the risk of unplanned reoperation (uro) after anterior resection for rectal cancer, utilizing data from 2,384 patients. The Random Forest model showed exceptional performance, achieving an accuracy of 84.2% and an AUC of 0.889. Key factors…

Int J Colorectal Dis7 Oct 2024

Powered circular stapler reduces complications in colorectal surgery

The systematic review and meta-analysis encompassing five studies and 2,379 patients reveals that using powered circular staplers (PCS) significantly lowers the rates of anastomotic leak (AL) and bleeding (AB) compared to manual circular staplers (MCS), with risk ratios of 0.44 and 0.23, respectively. However, no…

Asian J Endosc Surg6 Oct 2024

Laparoscopic surgery shows advantages for gastrointestinal perforations

In a study involving 219 patients, laparoscopic surgery for lower gastrointestinal perforations demonstrated significant advantages over open surgery. Median operative time was reduced (126 vs. 146 minutes), with far less intraoperative blood loss (50.4 ml vs. 400.1 ml). Patients undergoing laparoscopic procedures had a lower…

Br J Surg4 Oct 2024

Minimum Ablative Margin of 5 mm Ensures Optimal Outcomes

A multicentre study on colorectal liver metastases establishes that an intraprocedural minimum ablative margin of at least 5 mm significantly reduces the risk of local disease progression. With data from 400 ablated tumors across various institutions, findings reveal 3-year progression rates drop to below 1%…

Tech Coloproctol3 Oct 2024

Enhanced recovery protocols significantly reduce delayed recovery rates

Identifying key factors impacting recovery, clinicians analyzed data from 1,535 patients undergoing elective colorectal surgery across 22 hospitals. Despite a median adherence to protocols at 75%, 31.7% experienced delayed recovery. The study highlighted six critical protocol items, including pre-admission counseling and early removal of the…

Int J Colorectal Dis2 Oct 2024

Biological agents significantly reduce surgery rates in Crohn’s disease

In the era of biological agents, Crohn's disease patients show varying surgery rates based on Montreal classifications. Notably, type B3 patients have the highest likelihood of requiring surgery, while type A1 patients tend to undergo surgery earlier than A2 and A3. The use of biological…